{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:49:03Z","timestamp":1773888543495,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.contraception.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T02:08:50Z","timestamp":1468634930000},"page":"113-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Does the type of progestin influence the production of clotting factors?"],"prefix":"10.1016","volume":"95","author":[{"given":"Frank Z.","family":"Stanczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett W.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria K.","family":"Cortessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.07.007_bb0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.007_bb0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0015","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2016.07.007_bb0020","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.07.007_bb0025","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case\u2013control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.07.007_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.007_bb0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13625187.2011.643836","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis","volume":"17","author":"Martinez","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.07.007_bb0045","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","article-title":"Causation and causal inference in epidemiology","volume":"95","author":"Rothman","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2016.07.007_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: association of causation?","volume":"58","author":"Hill","year":"1965","journal-title":"J R Soc Med"},{"key":"10.1016\/j.contraception.2016.07.007_bb0055","doi-asserted-by":"crossref","first-page":"225.c","DOI":"10.1016\/j.blre.2009.07.002","article-title":"Basic mechanisms and pathogenesis of venous thrombosis","volume":"23","author":"Esmon","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.contraception.2016.07.007_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2016.07.007_bb0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2016.07.007_bb0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0022-4731(86)90098-1","article-title":"Hormonal control of SBP in human hepatoma cells","volume":"24","author":"Mercier-Bodard","year":"1986","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2016.07.007_bb0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0960-0760(90)90358-R","article-title":"Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line","volume":"10","author":"Edmunds","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-12-386933-3.00006-6","article-title":"G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis","volume":"114","author":"Shi","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.contraception.2016.07.007_bb0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2016.07.007_bb0090","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0022-4731(87)90197-X","article-title":"Estrogen receptors and androgen receptors in mammalian liver","volume":"27","author":"Eisenfeld","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2016.07.007_bb0095","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1538-7836.2010.03930.x","article-title":"17\u03b1-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor \u03b1","volume":"8","author":"Cleuren","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2016.07.007_bb0100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/me.2003-0441","article-title":"Genome-wide identification of high-affinity estrogen response elements in human and mouse","volume":"18","author":"Bourdeau","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0110","series-title":"Clinical gynecologic endocrinology and infertility","first-page":"691","year":"2005"},{"key":"10.1016\/j.contraception.2016.07.007_bb0115","series-title":"Proc 7th Int Congr Endocr","first-page":"373","article-title":"Human liver contains androgen and estrogen receptors","author":"Aten","year":"1984"},{"key":"10.1016\/j.contraception.2016.07.007_bb0120","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2265.1985.tb01108.x","article-title":"Identification and characterization of the human hepatic androgen receptor","volume":"23","author":"Bannister","year":"1985","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/09513599909167574","article-title":"The pharmacological profile of a novel norpregnance progestin (trimegestone)","volume":"13","author":"Philibert","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2016.07.007_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2016.07.007_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral coxntraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2016.07.007_bb0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2016.07.007_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","author":"Oral Contraceptive and Hemostasis Study Group","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.007_bb0150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00044-X","article-title":"An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables \u2014 outline of the protocol","volume":"59","author":"The Oral Contraceptive and Hemostasis Study Group","year":"1999","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:12:46Z","timestamp":1757880766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416301615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0010782416301615"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.007","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the type of progestin influence the production of clotting factors?","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}